Minimally Invasive Procedures Driving Market Growth: A Key Driver Transforming The Embolotherapy Market 2025

March 25, 2025 01:47 PM GMT | By EIN Presswire
 Minimally Invasive Procedures Driving Market Growth: A Key Driver Transforming The Embolotherapy Market 2025
Image source: EIN Presswire

The Business Research Company's Embolotherapy Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034

LONDON, GREATER LONDON, UNITED KINGDOM, March 25, 2025 /EINPresswire.com/ -- Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

The global embolotherapy market has shown a significant growth pattern in recent years. The market has witnessed an increase from $4.44 billion in 2024 to an estimated $4.86 billion in 2025, reflecting a compound annual growth rate CAGR of 9.3%. The robust growth over the past years can be ascribed to the escalating demand for embolotherapy in various therapeutic areas, including an increase in cancer cases, a higher prevalence rate of peripheral vascular diseases, amplified healthcare expenditure, and greater investment in research and development.

Is the Embolotherapy Market Set to Witness Substantial Growth?
The market size of embolotherapy is expected to continue its strong growth trajectory over the next few years. Forecasts peg the market size to reach $6.83 billion by 2029, growing at a compound annual growth rate CAGR of 8.9%. The primary factors driving this forecasted growth include elevated disposable income, a heightened prevalence of chronic diseases, an increasing adoption of embolotherapy in reproductive health, healthcare sector witnessing a surge in cheoembolization procedures and higher cases of liver cancer. The substantial growth in the forecast period will be characterized by trends such as innovations in technology, the advent of digital and analog devices, the insertion of cardiac monitors, advancements in embolotherapy techniques, and strategic collaborations within the industry.

Get Your Free Sample Market Report: https://www.thebusinessresearchcompany.com/sample_request?id=21181&type=smp

What Drives The Embolotherapy Market Growth?
Propelling this growth forward, the rising preference for minimally invasive procedures is expected to spur the embolotherapy market further. These minimally invasive procedures typically require little to no surgical intervention and are primarily cosmetic treatments, which involve minimal downtime and carry lower risks. The sway towards these procedures is supported by faster recovery times, reduced discomfort, minimal scarring, decreased complication risks, and technological advances. Embolotherapy, in particular, has contributed significantly to these minimally invasive procedures by blocking blood flow to targeted vessels selectively, thereby effectively reducing bleeding, treating tumors, and adeptly managing vascular abnormalities with superior precision and fewer complications.

Who Are The Key Players In The Embolotherapy Market?
Key companies operating in the embolotherapy market include Boston Scientific Corporation, Terumo Medical Corporation, Medtronic PLC, Johnson And Johnson, Stryker Corporation, Sirtex Medical, Abbott Laboratories, Acandis GmbH, Balt Group LLC, Penumbra Inc, Merit Medical Systems, Kaneka Corporation, Meril Life Sciences Pvt. Ltd., Shape Memory Medical Inc, Guerbet, IMBiotechnologies Ltd, Cardiva, Rapid Medical, Emboline Inc, Microport Scientific, Inari Medical, Instylla Inc, Embolx Inc, GE Healthcare, Lepu Medical Technology Co Ltd, WEGO HEALTHCARE SHENZHEN CO., LTD, Achieva Medical Inc, Varian Medical Systems Inc.

Order Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/embolotherapy-global-market-report

What Are The Emerging Trends In The Embolotherapy Market?
A significant trend observed in the embolotherapy market is the focus on innovative product development such as absorbable embolics systems to improve patient outcomes and expand treatment options. These absorbable embolic systems generally dissolve within the body over time, used in embolization procedures to block blood flow to said target tissues, such as tumors or aneurysms.

How Is The Embolotherapy Market Segmented?
1 Product: Embolization Coil, Embolic Agents, Detachable Balloons, Embolic Plug Systems, Support Devices
2 Application: Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Gastrointestinal GIT Disorders
3 Procedure: Transcatheter Arterial Embolization TAE, Transcatheter Arterial Radioembolization TARE Or Selective Internal Radiation Therapy SIRT, Transarterial Chemoembolization TACE
4 End User: Ambulatory Surgical Centre, Hospitals And Clinics, Other End Users.

With subsegments including:
1 Embolization Coil: Bare Coils, Coated Coils, Micro Coils
2 Embolic Agents: Liquid Embolic Agents, Particulate Embolic Agents, Gelatin Sponge, Polyvinyl Alcohol PVA Particles
3 Detachable Balloons: Single-Use Balloons, Multi-Use Balloons
4 Embolic Plug Systems: Plug Kits, Distal Occlusion Systems
5 Support Devices: Guidewires, Catheters, Sheath Introducers

What Is The Regional Analysis Of Embolotherapy Market?
In the regional analysis, North America emerged as the largest region in the embolotherapy market in 2024. However, Asia-Pacific is expected to witness the fastest growth in the forecast period. Other regions covered in the market report are Western Europe, Eastern Europe, South America, the Middle East, and Africa.

Explore more similar reports from The Business Research Company.

Coronary Artery Disease Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/coronary-artery-disease-global-market-report

Peripheral Artery Disease Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

Coronary Artery Bypass Graft Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/coronary-artery-bypass-graft-global-market-report

About The Business Research Company:
The Business Research Company boasts a repository of over 15000+ reports spanning 27 industries and 60+ geographies. It prides itself on comprehensive, data-rich research and insights. Armed with 1.5 million datasets, in-depth secondary research, and unique insights from industry leaders, it provides valuable data that helps you to stay ahead in the game.

Get in touch:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us: [email protected]

Stay connected:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


Investing Ideas

Previous Next